SCHEMBL6019928

SCHEMBL6019928

Cc1cc(C)c(S(=O)(=O)NCCC#N)c(C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.55
FABP4 P15090 1/20 0.54
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
MMP1 P03956 1/20 0.49
MMP2 P08253 1/20 0.49
MMP9 P14780 1/20 0.49
MMP8 P22894 1/20 0.49
MMP13 P45452 1/20 0.49
PDE4A P27815 1/20 0.48
PDE4B Q07343 1/20 0.48
PDE4C Q08493 1/20 0.48
PDE4D Q08499 1/20 0.48
LMNA P02545 2/20 0.48
NR2F2 P24468 1/20 0.48
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
THRB P10828 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7518858 0.90 FABP4 (0.58) L3MBTL1FABP4MEN1KMT2ACA1
SCHEMBL5562243 0.84 L3MBTL1 (0.67) L3MBTL1FABP4MEN1KMT2ACA1
SCHEMBL6825439 0.82 ALDH1A1 (0.46) L3MBTL1FABP4MEN1KMT2APDE4A
SCHEMBL5963342 0.80 FABP4 (0.76) L3MBTL1FABP4MEN1KMT2ACA1
SCHEMBL3687291 0.79 L3MBTL1 (0.61) L3MBTL1FABP4MEN1KMT2ACA1
SCHEMBL11448202 0.77 L3MBTL1 (0.59) L3MBTL1FABP4MEN1KMT2ACA1
SCHEMBL17101162 0.77 L3MBTL1 (0.59) L3MBTL1FABP4MEN1KMT2ACA1
SCHEMBL8576092 0.76 MAPT (0.69) L3MBTL1FABP4MEN1KMT2ACA1
SCHEMBL24269946 0.75 PDE4A (0.50) MEN1KMT2ACA2PDE4APDE4B
SCHEMBL4746858 0.75 FABP4 (0.68) L3MBTL1FABP4MEN1KMT2ACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060252813-A1 Apparatus for curing a composite laminate JERINI AG (DE) 2006-11-09 US claimed
EP-1433778-A1 Use of nitriles as rotamase inhibitors Jerini AG (DE) 2004-06-30 EP claimed
EP-1433779-A1 Use of nitriles as inhibitors of non-proteolytic enzymes Jerini AG (DE) 2004-06-30 EP claimed
US-20060252813-A1 Apparatus for curing a composite laminate JERINI AG (DE) 2006-11-09 US disclosed
EP-1433778-A1 Use of nitriles as rotamase inhibitors Jerini AG (DE) 2004-06-30 EP disclosed
EP-1433779-A1 Use of nitriles as inhibitors of non-proteolytic enzymes Jerini AG (DE) 2004-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252813-A1 Apparatus for curing a composite laminate DHX29, HDHD5, DHRS9 L3MBTL1 1177/4885FABP4 4528/4885MEN1 4215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.